• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions.如何测量 MDSC 的免疫抑制活性:检测方法、问题及潜在解决方案。
Cancer Immunol Immunother. 2019 Apr;68(4):631-644. doi: 10.1007/s00262-018-2170-8. Epub 2018 May 21.
2
Activated neutrophils exert myeloid-derived suppressor cell activity damaging T cells beyond repair.活化的中性粒细胞发挥髓源性抑制细胞活性,损害 T 细胞,使其无法修复。
Blood Adv. 2019 Nov 26;3(22):3562-3574. doi: 10.1182/bloodadvances.2019031609.
3
Presence of Infected Gr-1CD11bCD11c Monocytic Myeloid Derived Suppressor Cells Subverts T Cell Response and Is Associated With Impaired Dendritic Cell Function in -Infected Mice.感染的 Gr-1+CD11b+CD11c+单核细胞来源的髓系抑制细胞存在会颠覆 T 细胞反应,并与感染小鼠中树突状细胞功能受损有关。
Front Immunol. 2018 Oct 16;9:2317. doi: 10.3389/fimmu.2018.02317. eCollection 2018.
4
Myeloid-Derived Suppressor Cells Restrain Natural Killer Cell Activity in Acute Coxsackievirus B3-Induced Myocarditis.髓源性抑制细胞抑制急性柯萨奇病毒 B3 诱导的心肌炎中的自然杀伤细胞活性。
Viruses. 2021 May 12;13(5):889. doi: 10.3390/v13050889.
5
Myeloid-derived suppressor cells modulate B-cell responses.髓源性抑制细胞调节B细胞反应。
Immunol Lett. 2017 Aug;188:108-115. doi: 10.1016/j.imlet.2017.07.003. Epub 2017 Jul 4.
6
Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer.循环髓系来源抑制细胞(MDSC)在癌前病变中积累,与癌症中的 MDSC 具有表型和功能特征。
Front Immunol. 2019 Jun 19;10:1401. doi: 10.3389/fimmu.2019.01401. eCollection 2019.
7
Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets.人类髓源性抑制细胞亚群的临床相关性和抑制能力。
Clin Cancer Res. 2018 Oct 1;24(19):4834-4844. doi: 10.1158/1078-0432.CCR-17-3726. Epub 2018 Jun 18.
8
Granulocytic Myeloid-Derived Suppressor Cells (GR-MDSC) in Breast Milk (BM); GR-MDSC Accumulate in Human BM and Modulate T-Cell and Monocyte Function.母乳中的粒细胞-髓系来源抑制细胞(GR-MDSC);GR-MDSC 在人 BM 中积累并调节 T 细胞和单核细胞功能。
Front Immunol. 2018 May 17;9:1098. doi: 10.3389/fimmu.2018.01098. eCollection 2018.
9
Myeloid-Derived Suppressor Cells Specifically Suppress IFN-γ Production and Antitumor Cytotoxic Activity of Vδ2 T Cells.髓系来源的抑制细胞特异性抑制 IFN-γ 的产生和 Vδ2 T 细胞的抗肿瘤细胞毒性活性。
Front Immunol. 2018 Jun 6;9:1271. doi: 10.3389/fimmu.2018.01271. eCollection 2018.
10
Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates.解析髓系来源的抑制性细胞:在人类、小鼠和非人类灵长类动物中的分离和标志物。
Cancer Immunol Immunother. 2019 Apr;68(4):687-697. doi: 10.1007/s00262-019-02302-2. Epub 2019 Jan 25.

引用本文的文献

1
Aging modulates the immunosuppressive, polarizing and metabolic functions of blood-derived myeloid-derived suppressor cells (MDSCs).衰老调节血液来源的髓源性抑制细胞(MDSC)的免疫抑制、极化和代谢功能。
Immun Ageing. 2025 Jul 8;22(1):29. doi: 10.1186/s12979-025-00524-w.
2
Early Elevation of Monocytic-to-Polymorphonuclear Myeloid-Derived Suppressor Cells Ratio in Critical Illness is Associated with Favorable Clinical Outcomes.危重症患者中单核细胞与多形核骨髓来源抑制细胞比例的早期升高与良好临床结局相关。
J Inflamm Res. 2025 May 27;18:6807-6819. doi: 10.2147/JIR.S517333. eCollection 2025.
3
The predictive value of peripheral blood monocytic myeloid-derived suppressor cells for survival and immunotherapy responses in tumor patients.外周血单核细胞来源的髓系抑制细胞对肿瘤患者生存及免疫治疗反应的预测价值
BMC Immunol. 2025 May 24;26(1):41. doi: 10.1186/s12865-025-00722-7.
4
A novel method for isolation of tumor infiltrating myeloid-derived suppressor cells from human lung tumor tissue.一种从人肺肿瘤组织中分离肿瘤浸润性髓源性抑制细胞的新方法。
Sci Rep. 2025 Apr 30;15(1):15175. doi: 10.1038/s41598-025-99877-x.
5
Utilizing Nanoparticles to Overcome Anti-PD-1/PD-L1 Immunotherapy Resistance in Non-Small Cell Lung cancer: A Potential Strategy.利用纳米颗粒克服非小细胞肺癌中抗PD-1/PD-L1免疫疗法耐药性:一种潜在策略。
Int J Nanomedicine. 2025 Feb 25;20:2371-2394. doi: 10.2147/IJN.S505539. eCollection 2025.
6
Polymorphonuclear myeloid-derived suppressor cells regulates immune recovery during HIV infection through PD-L1 and TGF-β pathways.多形核骨髓来源的抑制性细胞通过PD-L1和TGF-β途径调节HIV感染期间的免疫恢复。
Front Cell Infect Microbiol. 2024 Dec 17;14:1516421. doi: 10.3389/fcimb.2024.1516421. eCollection 2024.
7
Novel insight and perspectives of nanoparticle-mediated gene delivery and immune-modulating therapies for pancreatic cancer.纳米颗粒介导的胰腺癌基因递送与免疫调节疗法的新见解与展望
J Nanobiotechnology. 2024 Dec 19;22(1):771. doi: 10.1186/s12951-024-02975-7.
8
Characterization of myeloid-derived suppressor cells in the peripheral blood and bone marrow of patients with chronic idiopathic neutropenia.慢性特发性中性粒细胞减少症患者外周血和骨髓中髓源性抑制细胞的特征分析
Hemasphere. 2024 Sep 23;8(9):e70005. doi: 10.1002/hem3.70005. eCollection 2024 Sep.
9
Shifting phenotype and differentiation of CD11bGr.1 immature heterogeneous myeloid derived adjuster cells support inflammation and induce regulators of IL17A in imiquimod induced psoriasis.CD11bGr.1 幼稚异质性髓系来源的调节细胞的表型转变和分化支持炎症,并在咪喹莫特诱导的银屑病中诱导 IL17A 的调节因子。
Inflamm Res. 2024 Sep;73(9):1581-1599. doi: 10.1007/s00011-024-01918-0. Epub 2024 Jul 25.
10
Impact of high-salt diet in health and diseases and its role in pursuit of cancer immunotherapy by modulating gut microbiome.高盐饮食对健康和疾病的影响及其通过调节肠道微生物群在癌症免疫治疗中的作用。
J Family Med Prim Care. 2024 May;13(5):1628-1635. doi: 10.4103/jfmpc.jfmpc_1574_23. Epub 2024 May 24.

本文引用的文献

1
Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell Function.髓系来源的抑制细胞产生的一氧化氮在损害 Fc 受体介导的自然杀伤细胞功能中起作用。
Clin Cancer Res. 2018 Apr 15;24(8):1891-1904. doi: 10.1158/1078-0432.CCR-17-0691. Epub 2018 Jan 23.
2
Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells.通过选择性清除粒细胞性髓细胞逆转对CTLA-4检查点抑制的抗性。
Oncotarget. 2017 Jun 11;8(34):55804-55820. doi: 10.18632/oncotarget.18437. eCollection 2017 Aug 22.
3
Visualization of Tumor-Immune Interaction - Target-Specific Imaging of S100A8/A9 Reveals Pre-Metastatic Niche Establishment.肿瘤-免疫相互作用的可视化——S100A8/A9的靶向特异性成像揭示了转移前生态位的建立。
Theranostics. 2017 Jun 15;7(9):2392-2401. doi: 10.7150/thno.17138. eCollection 2017.
4
Myeloid-derived suppressor cells-a new therapeutic target to overcome resistance to cancer immunotherapy.髓源性抑制细胞——克服癌症免疫治疗耐药性的新治疗靶点。
J Leukoc Biol. 2017 Sep;102(3):727-740. doi: 10.1189/jlb.5VMR1116-458RRR. Epub 2017 May 25.
5
Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma.伊匹单抗治疗可减少晚期黑色素瘤长期存活者的单核细胞源性髓系抑制细胞,并增加CD8效应记忆T细胞。
Oncotarget. 2017 Mar 28;8(13):21539-21553. doi: 10.18632/oncotarget.15368.
6
Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients.凝集素型氧化型低密度脂蛋白受体-1可区分癌症患者中人类多形核髓源性抑制细胞群体。
Sci Immunol. 2016 Aug;1(2). doi: 10.1126/sciimmunol.aaf8943. Epub 2016 Aug 5.
7
Myeloid cells in circulation and tumor microenvironment of breast cancer patients.乳腺癌患者循环系统和肿瘤微环境中的髓样细胞。
Cancer Immunol Immunother. 2017 Jun;66(6):753-764. doi: 10.1007/s00262-017-1977-z. Epub 2017 Mar 10.
8
Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients.免疫抑制性骨髓来源的抑制细胞在癌症患者的脾细胞中增多。
Cancer Immunol Immunother. 2017 Apr;66(4):503-513. doi: 10.1007/s00262-016-1953-z. Epub 2017 Jan 20.
9
Myeloid-Derived Suppressor Cells.髓系来源的抑制细胞
Cancer Immunol Res. 2017 Jan;5(1):3-8. doi: 10.1158/2326-6066.CIR-16-0297.
10
Increased Levels of Circulating and Tumor-Infiltrating Granulocytic Myeloid Cells in Colorectal Cancer Patients.结直肠癌患者循环及肿瘤浸润粒细胞性髓样细胞水平升高。
Front Immunol. 2016 Dec 8;7:560. doi: 10.3389/fimmu.2016.00560. eCollection 2016.

如何测量 MDSC 的免疫抑制活性:检测方法、问题及潜在解决方案。

How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions.

机构信息

de Duve Institute, Université catholique de Louvain, Avenue Hippocrate 74, 1200, Brussels, Belgium.

Institute of Immunology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany and Faculty of Mathematics and Natural Sciences, University of Greifswald, Greifswald, Germany.

出版信息

Cancer Immunol Immunother. 2019 Apr;68(4):631-644. doi: 10.1007/s00262-018-2170-8. Epub 2018 May 21.

DOI:10.1007/s00262-018-2170-8
PMID:29785656
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11028070/
Abstract

Myeloid-derived suppressor cells (MDSC) are a heterogeneous group of mononuclear and polymorphonuclear myeloid cells, which are present at very low numbers in healthy subjects, but can expand substantially under disease conditions. Depending on disease type and stage, MDSC comprise varying amounts of immature and mature differentiation stages of myeloid cells. Validated unique phenotypic markers for MDSC are still lacking. Therefore, the functional analysis of these cells is of central importance for their identification and characterization. Various disease-promoting and immunosuppressive functions of MDSC are reported in the literature. Among those, the capacity to modulate the activity of T cells is by far the most often used and best-established read-out system. In this review, we critically evaluate the assays available for the functional analysis of human and murine MDSC under in vitro and in vivo conditions. We also discuss critical issues and controls associated with those assays. We aim at providing suggestions and recommendations useful for the contemporary biological characterization of MDSC.

摘要

髓系来源的抑制细胞 (MDSC) 是一群异质性的单核细胞和多形核髓系细胞,在健康个体中数量非常少,但在疾病状态下可以大量扩增。根据疾病类型和阶段的不同,MDSC 包含不同数量的未成熟和成熟的髓系细胞分化阶段。目前仍缺乏 MDSC 的特异性表型标记物。因此,这些细胞的功能分析对于它们的鉴定和特征描述至关重要。文献中报道了 MDSC 的多种促进疾病和免疫抑制功能。其中,调节 T 细胞活性的能力是迄今为止最常用和最成熟的检测系统。在这篇综述中,我们批判性地评估了在体外和体内条件下用于分析人类和鼠 MDSC 功能的可用检测方法。我们还讨论了与这些检测方法相关的关键问题和对照。我们的目的是为 MDSC 的当代生物学特征提供有用的建议和建议。